Dr. Mikhael is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10510 N 92nd Street Suite 200
Scottsdale, AZ 85258Phone+1 480-323-1350- Is this information wrong?
Education & Training
University of Ottawa Faculty of MedicineClass of 1997
Certifications & Licensure
AZ State Medical License 2007 - 2025
Clinical Trials
- Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction Start of enrollment: 2009 Jan 21
- Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma Start of enrollment: 2009 Jun 01
- Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Isatuximab in combination with carfilzomib and dexamethasone in 1q21+ patients with relapsed/refractory multiple myeloma: Long-term outcomes in the Phase 3 IKEMA study.Facon, T., Moreau, P., Špicka, I., Suzuki, K., Yong, K., Fukao, T., Bisht, K., Armstrong, N., Macé, S., Risse, M., Martin, T., Mikhael, J.> ;Hematological Oncology. 2024 Mar 1
- Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indire...Katja Weisel, Meletios A Dimopoulos, Meral Beksac, Xavier Leleu, Joshua Richter, Bart Heeg, Sachin Patel, Istvan Majer, Ian McFadden, Joseph Mikhael> ;Leukemia & Lymphoma. 2024 Apr 1
- Addressing the disparities: the approach to the African American patient with multiple myeloma.Bhutani, M., Blue, B., Cole, C., Badros, A., Usmani, S., Nooka, A., Bernal-Mizrachi, L., Mikhael, J.> ;Blood Cancer Journal. 2023 Dec 18
- Join now to see all
Abstracts/Posters
- The Global State of Hematopoietic Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Datab...Joseph Mikhael, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Relationship between Baseline Biomarkers and Efficacy of Isatuximab in Combination with Pomalidomide and Dexamethasone in RRMM: Insights from Phase 1 and Phase 3 S...Joseph Mikhael, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Show Me the Money: Negotiating Your First Job60th American Society of Hematology Annual Meeting - 11/30/2018
- Final results of a phase Ib study of isatuximab (ISA) plus pomalidomide (Pom) and dexamethasone (dex) in relapsed/refractory multiple myeloma (RRMM).2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Join now to see all
Press Mentions
Janssen Launches Health Equity Campaign in Partnership with Award-Winning Radio Host D.L. Hughley to Raise Awareness About Multiple Myeloma Among Black CommunitiesMarch 2nd, 2023- City of Hope Researchers Present Innovative Studies at American Society of Hematology (ASH) Annual MeetingDecember 13th, 2022
- FDA Approves New CAR T Cancer Therapy for Form of Multiple MyelomaFebruary 28th, 2022
- Join now to see all
Hospital Affiliations
HonorHealth Scottsdale Shea Medical CenterScottsdale, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
